Nasdaq, Inc. reports developments across its market infrastructure, index, data, listings and financial technology businesses. Company news commonly covers monthly trading volumes, quarterly volume and listings statistics, earnings releases, dividend announcements, and operating trends in divisions such as Financial Technology.
Nasdaq updates also include changes to the Nasdaq-100 Index and other Nasdaq Global Indexes, trading halt and resumption notices from The Nasdaq Stock Market, and corporate governance or capital-structure matters. Its financial technology activities include solutions tied to capital management, financial crime and regulatory compliance software.
Summary not available.
Summary not available.
Nasdaq (NDAQ) will announce its Fourth Quarter 2020 financial results on January 27, 2021, at 8:00 AM Eastern. The announcement will be accompanied by a conference call featuring Nasdaq's CEO, CFO, and senior management. Participants can access the call via the Nasdaq Investor Relations website. An audio replay will be available afterward. The press release will be published on the Investor Relations website earlier that day at approximately 7:00 AM Eastern. This event offers insights into Nasdaq's latest financial performance and strategic direction.
In 2020, Nasdaq (NDAQ) led the U.S. exchange market by welcoming 300 IPOs, raising a total of $77.86 billion, marking its largest IPO year in the past decade. With an 83% success rate for operating companies, Nasdaq also attracted 21 firms switching from the NYSE, representing $278 billion in market value. Significant IPOs included Airbnb and Warner Music Group. Nasdaq's initiatives to modernize SEC rules further underscore its commitment to enhancing market integrity. The exchange continues to dominate sectors like Health Care and Technology, achieving impressive win rates in venture and private equity-backed listings.
Summary not available.
Nasdaq (Nasdaq: NDAQ) will implement its annual reconstitution of the Nasdaq-100 Index® on December 21, 2020. Six companies will join the index, including American Electric Power Company, Marvell Technology Group, and Peloton Interactive. The reconstitution process involves adding and removing companies based on market capitalization, with the new additions replacing companies like BioMarin Pharmaceutical and Take-Two Interactive. The Nasdaq-100 Index serves as a benchmark for various financial products and is crucial for market performance tracking.
On December 11, 2020, Nasdaq (NDAQ) announced the reconstitution of the Nasdaq Biotechnology Index (NBI), effective December 21, 2020. This annual adjustment will include 100 new biotech and pharmaceutical securities, enhancing the index's representation in the sector. Notable additions are Arbutus Biopharma, Adaptimmune Therapeutics, and BioNTech, among others. Conversely, 16 securities will be removed from the index, including ADMA Biologics and Myris, Inc. The changes aim to better reflect market trends and advance investor insights into the biotech landscape.
Summary not available.
Nasdaq, Inc. (NDAQ) has announced a public offering totaling $1.9 billion in senior notes with varying maturity dates: $600 million at 0.445% due in 2022, $650 million at 1.650% due in 2031, and $650 million at 2.500% due in 2040. The net proceeds will finance the acquisition of Verafin, cover its outstanding debts, and support general corporate needs. The offering closes on December 21, 2020, pending customary conditions.
Nasdaq, Inc. (NDAQ) announced its plan to offer senior notes, subject to market conditions, to finance its pending acquisition of Verafin Holdings Inc. The expected net proceeds will also be used to repay Verafin's outstanding debts and for general corporate purposes. Major banks, including J.P. Morgan and Goldman Sachs, will manage the Offering. The Offering will be conducted under a previously filed shelf registration with the SEC and will include forward-looking statements about potential risks and market conditions.